| Bioactivity | (R)-BDP9066 is a potent inhibitor of myotonic dystrophy kinase-related Cdc42-binding kinase (MRCK). (R)-BDP9066 blocks cancer cell invasion. (R)-BDP9066 has the potential for the research of proliferative diseases, such as cancer. | ||||||||||||
| Name | (R)-BDP9066 | ||||||||||||
| CAS | 2284549-25-1 | ||||||||||||
| Formula | C20H24N6 | ||||||||||||
| Molar Mass | 348.44 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Pyrrolo[2,3-b]pyridine compounds and their use in the treatment of cancer. Patent WO2019034890A1. |
(R)-BDP9066
CAS: 2284549-25-1 F: C20H24N6 W: 348.44
(R)-BDP9066 is a potent inhibitor of myotonic dystrophy kinase-related Cdc42-binding kinase (MRCK). (R)-BDP9066 blocks c
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.